Bosutinib Teva

Bosutinib Teva is a medication used for targeted therapy in certain types of cancer. This oral medication is designed to inhibit specific proteins involved in cancer cell growth.

Bosutinib Teva is primarily used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It works by targeting and blocking proteins that contribute to the growth of cancer cells. Patients often wonder, 'What is Bosutinib used for?' and the answer lies in its role as a tyrosine kinase inhibitor, which helps manage these specific types of leukemia.

Common effects of Bosutinib Teva may include gastrointestinal issues such as nausea, diarrhea, and vomiting. Some users also report fatigue, rash, or changes in liver function. These effects can vary widely among individuals and are not exhaustive.

Bosutinib Teva should be handled with care, especially regarding liver function. Regular monitoring is advised. It is important to follow healthcare provider instructions and report any severe or persistent side effects. Always store the medication as directed to maintain its efficacy.

Bosutinib Teva may interact with certain medications, including those that affect liver enzymes like CYP3A4. This can alter the effectiveness of Bosutinib. It is also advisable to avoid grapefruit products, as they can interfere with the metabolism of the drug. Always consult a healthcare provider before starting or stopping any medication.